Immunotherapy Combo Stops Rare, Stage 4 Sarcoma in Teenage Patient
Oct 16, 2020 AM EDT
A new study showed, a patient who has "end-stage and quickly developing soft-tissue cancer whose tumor" was not responsive to standard treatment, had a "rapid and complete response" to an innovative combination of immunotherapy.